In a prospective randomized study in familial hypertrophic cardiomyopathy, metoprolol maintains exercise-performance, with lower myocardial oxygen-cost, and prevents deterioration in exercise-ability
1 September 2019 (10:05 - 10:55)
Organised by:
Abstract
Slides
About the speaker
Sahlgrenska Academy - University of Gothenburg, Gothenburg (Sweden)
5 More presentations in this session
Doctor C. Fumagalli (Naples, IT)
Mr R. Huurman (Rotterdam, NL)
Mr G. Chatzantonis (Munster, DE)
Access the full session
The Event
ESC Congress 2019
1 September 2019
10:05 CET
